Business Description
Valiant Laboratories Ltd
ISIN : INE0JWS01017
Total Employee Number:
79Compare
Compare
Traded in other countries / regions
543998.India IPO Date
2023-10-06Description
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 5.3 | |||||
Interest Coverage | 0.19 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.23 | |||||
Beneish M-Score | -2.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.6 | |||||
3-Year EBITDA Growth Rate | -45.8 | |||||
3-Year Book Growth Rate | 38.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.15 | |||||
9-Day RSI | 39.79 | |||||
14-Day RSI | 41.1 | |||||
3-1 Month Momentum % | 37.08 | |||||
6-1 Month Momentum % | 3.89 | |||||
12-1 Month Momentum % | -27.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.91 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 47.17 | |||||
Days Sales Outstanding | 113.52 | |||||
Days Payable | 113.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.1 | |||||
Shareholder Yield % | 15.97 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.98 | |||||
Operating Margin % | 0.15 | |||||
Net Margin % | -1.38 | |||||
EBITDA Margin % | 3.67 | |||||
FCF Margin % | -18.8 | |||||
OCF Margin % | -4.39 | |||||
ROE % | -1.14 | |||||
ROA % | -0.76 | |||||
ROC (Joel Greenblatt) % | 0.89 | |||||
ROCE % | 0.77 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.46 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 1.16 | |||||
EV-to-EBIT | 139.7 | |||||
EV-to-EBITDA | 42.98 | |||||
EV-to-Revenue | 1.58 | |||||
EV-to-FCF | -8.4 | |||||
Price-to-GF-Value | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 4.81 | |||||
Earnings Yield (Greenblatt) % | 0.72 | |||||
FCF Yield % | -12.33 | |||||
Forward Rate of Return (Yacktman) % | -61.87 |
Valiant Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valiant Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Valiant Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers